Structural and functional evidence that initiation and elongation of HIV-1 reverse transcription are distinct processes

Retroviral reverse transcription starts with the extension of a cellular tRNA primer bound near the 5′ end of the viral genomic RNA at a site called the primer binding site (PBS). Formation of the HIV-1 initiation complex between tRNA 3 Lys, viral RNA and reverse transcriptase probably occurs during...

Full description

Saved in:
Bibliographic Details
Published inBiochimie Vol. 78; no. 11; pp. 1087 - 1096
Main Authors Lanchy, J.M., Isel, C., Ehresmann, C., Marquet, R., Ehresmann, B.
Format Journal Article
LanguageEnglish
Published France Elsevier Masson SAS 1996
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Retroviral reverse transcription starts with the extension of a cellular tRNA primer bound near the 5′ end of the viral genomic RNA at a site called the primer binding site (PBS). Formation of the HIV-1 initiation complex between tRNA 3 Lys, viral RNA and reverse transcriptase probably occurs during encapsidation of these components. tRNA 3 Lys is thought to be selectively packaged by interaction with the reverse transcriptase domain of the Pr160 Gag-Pol precursor protein, then annealed to the PBS of viral RNA with the help of the nucleocapsid protein. tRNA 3 Lys and HIV-1 viral RNA form a highly-structured complex, with extended interactions between the two molecules. Two different modes of reverse transcription have been distinguished: initiation, a tRNA 3 Lys-specific and distributive mode of polymerization corresponding to the addition of the first five nucleotides, followed by elongation, a non-specific and processive mode of DNA synthesis. These two modes are reminiscent of the initiation and elongation processes previously observed with DNA-dependent RNA polymerases.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-3
ObjectType-Review-1
ISSN:0300-9084
1638-6183
DOI:10.1016/S0300-9084(97)86734-X